1 New Data and How They Change What We Know About Heart Failure
2
3 ESC Guidelines for HF: Patient With HFrEF
4 Vicious Cycle of Congestion in Acute HF
5 Recent Acute HF Trials
6 Goals of Treatment in Acute HF
7 Patient With Acute HF
8 Management of Evidence Based Oral Therapies
9 After Initial Stabilization…What’s Next?
10 Initial Management of a Patient With Acute HF
11 HFpEF Trials
12 HFpEF: TOPCAT [a] Results By Region
13 ESC Guidelines: HFpEF
14 ACC/AHA/HFSA Guidelines: HFpEF
15 ESC Guidelines: Definition of the Type of HF
16 What We Do Know About HFmrEF?
17 CHARM: Candesartan Reduced CV Death and Time to First HF Hospitalization in HFrEF and HFmrEF Categories
18 Implementation of New Therapies in HF
19 PARADIGM-HF Primary Results: Significant Reduction in Primary Endpoints, CV Death, and All-Cause Mortality
20 How Do We Better Optimize Treatment?
21 Conclusions
22 Abbreviations
23 Abbreviations (cont)
24